February Business Bits

  • Roche Molecular Diagnostics has released the first commercial test available in the U.S. to simultaneously measure quantities of parvovirus B19 and detect hepatitis A virus in human plasma, offering a significant advancement over existing techniques. Human plasma may be used to create treatments for life-threatening and chronic diseases and disorders such as hemophilia, in treating those who have suffered severe burns or trauma, and has many other therapeutic uses.

    "The launch of this test is an important part of our strategy," said Paul Brown, head of Roche Molecular Diagnostics. "Not only is it an important test for the continued safety of plasma products, but it also indicates our continued commitment to this vital area."

  • Hacienda's Visioneer, Inc., is partnering with Cranel Imaging to distribute select Visioneer and Xerox DocuMate scanners for the healthcare industry in the U.S. and Canada, combining their expertise in healthcare solutions to provide resellers a new advantage in the growing Electronic Healthcare Record (EHR) market segments.

    "Today less than 34% of healthcare institutions have a deployed a full EHR system to address compliancy through US Department of Health and Human Services," said Bill Kouzi, senior vice president of sales at Visioneer. "This affects their ability to qualify for 2011 incentive payments and we at Visioneer feel there is a tremendous opportunity with Cranel Imaging to address this opportunity."

    The agreement allows qualified healthcare partners to access bundled hardware and service solutions that address a broad base of healthcare applications targeting the expansion of EHR systems and their deployment.

  • Veeva Systems has launched the pharmaceutical industry's first customer relationship management (CRM) and closed-loop marketing (CLM) application built exclusively for Apple's popular iPad tablet. Dubbed Veeva iRep, the software includes a content viewer that allows users to deliver interactive presentations, including visual data and video content, in addition to Veeva's CRM functionality. In addition, the iPad's mobile Internet connectivity means that sales representatives will have real-time access to additional resources, further enhancing customer interactions.

    "The iPad arrived just in time for pharma," said Matt Wallach, chief strategy officer at Veeva Systems. "Reps are under pressure to represent more products against more competition while physicians give them less face time to do so. iRep allows them to be more efficient, more effective, and more connected. The real-time rep has truly arrived."

Also in this issue ...

Share this page!